Health Conditions Why Merck’s antiviral capsule isn’t a silver bullet for COVID October 9, 2021 / Why Merck’s antiviral capsule isn’t a silver bullet for COVID | Fortune It is advisable to allow JavaScript to view this website. https://fortune.com/2021/10/07/mercks-antiviral-pill-covid/